Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Invivoscribe Submits FLT3 Mutation Assay CDx to Japanese Regulators

Invivoscribe Submits FLT3 Mutation Assay CDx to Japanese Regulators

Nov 19, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Invivoscribe announced today that it has submitted its LeukoStrat CDx FLT3 Mutation Assay to Japanese regulators as a companion diagnostic for Daiichi Sankyo's acute myeloid leukemia drug quizartinib.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  2. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  3. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  4. Lucira Health Files for $115M IPO

  5. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.